Active Pharmaceutical Ingredient (API) Market Size, Share & Trends Report by Manufacturer (Captive & Merchant), Synthesis (Synthetic & Biological), Drug Type (Generic & Branded), Therapeutic Area (Cardiovascular, Metabolic, CNS, Oncology, Musculoskeletal, NSAIDs & Others), and Region (North America, Europe, Asia Pacific, Rest of World) – Industry Analysis & Forecast To 2032
Market Executive Summary
The global market for Active Pharmaceutical Ingredient(API) was estimated to be worth US$ 234 million in 2024 and is forecast to a readjusted size of US$ 351 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022.
The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Active Pharmaceutical Ingredient(API), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Active Pharmaceutical Ingredient(API) by region & country, by Type, and by Application.
The Active Pharmaceutical Ingredient(API) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Active Pharmaceutical Ingredient(API).
Global Active Pharmaceutical Ingredient(API) Companies Covered
Teva Pharmaceuticals, Pfizer, Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Novartis, Mylan, Boehringer Ingelheim, Merck & Co., AbbVie, Biocon, Bristol Myers Squibb, C.H. Boehringer Sohn AG & Co. KG, Cipla, Albemarle Corporation, Viatris, Dr. Reddy's Laboratories
Global Active Pharmaceutical Ingredient(API) Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Active Pharmaceutical Ingredient(API) Market, Segment by Type
Generic API
Innovative API
Global Active Pharmaceutical Ingredient(API) Market, Segment by Application
Oncology
Cardiology
Cns and Neurology
Orthopaedic
Pulmonology
Gastroenterology
Nephrology
Ophthalmology
Endocrinology
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Active Pharmaceutical Ingredient(API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Active Pharmaceutical Ingredient(API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Active Pharmaceutical Ingredient(API) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
Table of Contents
1 Market Overview
1.1 Active Pharmaceutical Ingredient(API) Product Introduction
1.2 Global Active Pharmaceutical Ingredient(API) Market Size Forecast
1.2.1 Global Active Pharmaceutical Ingredient(API) Sales Value (2020-2031)
1.2.2 Global Active Pharmaceutical Ingredient(API) Sales Volume (2020-2031)
1.2.3 Global Active Pharmaceutical Ingredient(API) Sales Price (2020-2031)
1.3 Active Pharmaceutical Ingredient(API) Market Trends & Drivers
1.3.1 Active Pharmaceutical Ingredient(API) Industry Trends
1.3.2 Active Pharmaceutical Ingredient(API) Market Drivers & Opportunity
1.3.3 Active Pharmaceutical Ingredient(API) Market Challenges
1.3.4 Active Pharmaceutical Ingredient(API) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Active Pharmaceutical Ingredient(API) Players Revenue Ranking (2024)
2.2 Global Active Pharmaceutical Ingredient(API) Revenue by Company (2020-2025)
2.3 Global Active Pharmaceutical Ingredient(API) Players Sales Volume Ranking (2024)
2.4 Global Active Pharmaceutical Ingredient(API) Sales Volume by Company Players (2020-2025)
2.5 Global Active Pharmaceutical Ingredient(API) Average Price by Company (2020-2025)
2.6 Key Manufacturers Active Pharmaceutical Ingredient(API) Manufacturing Base and Headquarters
2.7 Key Manufacturers Active Pharmaceutical Ingredient(API) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Active Pharmaceutical Ingredient(API)
2.9 Active Pharmaceutical Ingredient(API) Market Competitive Analysis
2.9.1 Active Pharmaceutical Ingredient(API) Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Active Pharmaceutical Ingredient(API) Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredient(API) as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Generic API
3.1.2 Innovative API
3.2 Global Active Pharmaceutical Ingredient(API) Sales Value by Type
3.2.1 Global Active Pharmaceutical Ingredient(API) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Active Pharmaceutical Ingredient(API) Sales Value, by Type (2020-2031)
3.2.3 Global Active Pharmaceutical Ingredient(API) Sales Value, by Type (%) (2020-2031)
3.3 Global Active Pharmaceutical Ingredient(API) Sales Volume by Type
3.3.1 Global Active Pharmaceutical Ingredient(API) Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Active Pharmaceutical Ingredient(API) Sales Volume, by Type (2020-2031)
3.3.3 Global Active Pharmaceutical Ingredient(API) Sales Volume, by Type (%) (2020-2031)
3.4 Global Active Pharmaceutical Ingredient(API) Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oncology
4.1.2 Cardiology
4.1.3 Cns and Neurology
4.1.4 Orthopaedic
4.1.5 Pulmonology
4.1.6 Gastroenterology
4.1.7 Nephrology
4.1.8 Ophthalmology
4.1.9 Endocrinology
4.2 Global Active Pharmaceutical Ingredient(API) Sales Value by Application
4.2.1 Global Active Pharmaceutical Ingredient(API) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Active Pharmaceutical Ingredient(API) Sales Value, by Application (2020-2031)
4.2.3 Global Active Pharmaceutical Ingredient(API) Sales Value, by Application (%) (2020-2031)
4.3 Global Active Pharmaceutical Ingredient(API) Sales Volume by Application
4.3.1 Global Active Pharmaceutical Ingredient(API) Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Active Pharmaceutical Ingredient(API) Sales Volume, by Application (2020-2031)
4.3.3 Global Active Pharmaceutical Ingredient(API) Sales Volume, by Application (%) (2020-2031)
4.4 Global Active Pharmaceutical Ingredient(API) Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Active Pharmaceutical Ingredient(API) Sales Value by Region
5.1.1 Global Active Pharmaceutical Ingredient(API) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Active Pharmaceutical Ingredient(API) Sales Value by Region (2020-2025)
5.1.3 Global Active Pharmaceutical Ingredient(API) Sales Value by Region (2026-2031)
5.1.4 Global Active Pharmaceutical Ingredient(API) Sales Value by Region (%), (2020-2031)
5.2 Global Active Pharmaceutical Ingredient(API) Sales Volume by Region
5.2.1 Global Active Pharmaceutical Ingredient(API) Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Active Pharmaceutical Ingredient(API) Sales Volume by Region (2020-2025)
5.2.3 Global Active Pharmaceutical Ingredient(API) Sales Volume by Region (2026-2031)
5.2.4 Global Active Pharmaceutical Ingredient(API) Sales Volume by Region (%), (2020-2031)
5.3 Global Active Pharmaceutical Ingredient(API) Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Active Pharmaceutical Ingredient(API) Sales Value, 2020-2031
5.4.2 North America Active Pharmaceutical Ingredient(API) Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Active Pharmaceutical Ingredient(API) Sales Value, 2020-2031
5.5.2 Europe Active Pharmaceutical Ingredient(API) Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Active Pharmaceutical Ingredient(API) Sales Value, 2020-2031
5.6.2 Asia Pacific Active Pharmaceutical Ingredient(API) Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Active Pharmaceutical Ingredient(API) Sales Value, 2020-2031
5.7.2 South America Active Pharmaceutical Ingredient(API) Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Value, 2020-2031
5.8.2 Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Active Pharmaceutical Ingredient(API) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Active Pharmaceutical Ingredient(API) Sales Value
6.2.1 Key Countries/Regions Active Pharmaceutical Ingredient(API) Sales Value, 2020-2031
6.2.2 Key Countries/Regions Active Pharmaceutical Ingredient(API) Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Active Pharmaceutical Ingredient(API) Sales Value, 2020-2031
6.3.2 United States Active Pharmaceutical Ingredient(API) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Active Pharmaceutical Ingredient(API) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Active Pharmaceutical Ingredient(API) Sales Value, 2020-2031
6.4.2 Europe Active Pharmaceutical Ingredient(API) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Active Pharmaceutical Ingredient(API) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Active Pharmaceutical Ingredient(API) Sales Value, 2020-2031
6.5.2 China Active Pharmaceutical Ingredient(API) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Active Pharmaceutical Ingredient(API) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Active Pharmaceutical Ingredient(API) Sales Value, 2020-2031
6.6.2 Japan Active Pharmaceutical Ingredient(API) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Active Pharmaceutical Ingredient(API) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Active Pharmaceutical Ingredient(API) Sales Value, 2020-2031
6.7.2 South Korea Active Pharmaceutical Ingredient(API) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Active Pharmaceutical Ingredient(API) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Active Pharmaceutical Ingredient(API) Sales Value, 2020-2031
6.8.2 Southeast Asia Active Pharmaceutical Ingredient(API) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Active Pharmaceutical Ingredient(API) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Active Pharmaceutical Ingredient(API) Sales Value, 2020-2031
6.9.2 India Active Pharmaceutical Ingredient(API) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Active Pharmaceutical Ingredient(API) Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Teva Pharmaceuticals
7.1.1 Teva Pharmaceuticals Company Information
7.1.2 Teva Pharmaceuticals Introduction and Business Overview
7.1.3 Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Product Offerings
7.1.5 Teva Pharmaceuticals Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Information
7.2.2 Pfizer Introduction and Business Overview
7.2.3 Pfizer Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Pfizer Active Pharmaceutical Ingredient(API) Product Offerings
7.2.5 Pfizer Recent Development
7.3 Aurobindo Pharma
7.3.1 Aurobindo Pharma Company Information
7.3.2 Aurobindo Pharma Introduction and Business Overview
7.3.3 Aurobindo Pharma Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Aurobindo Pharma Active Pharmaceutical Ingredient(API) Product Offerings
7.3.5 Aurobindo Pharma Recent Development
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Sun Pharmaceutical Industries Ltd. Company Information
7.4.2 Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
7.4.3 Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Product Offerings
7.4.5 Sun Pharmaceutical Industries Ltd. Recent Development
7.5 Novartis
7.5.1 Novartis Company Information
7.5.2 Novartis Introduction and Business Overview
7.5.3 Novartis Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Novartis Active Pharmaceutical Ingredient(API) Product Offerings
7.5.5 Novartis Recent Development
7.6 Mylan
7.6.1 Mylan Company Information
7.6.2 Mylan Introduction and Business Overview
7.6.3 Mylan Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Mylan Active Pharmaceutical Ingredient(API) Product Offerings
7.6.5 Mylan Recent Development
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Information
7.7.2 Boehringer Ingelheim Introduction and Business Overview
7.7.3 Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Product Offerings
7.7.5 Boehringer Ingelheim Recent Development
7.8 Merck&Co.
7.8.1 Merck&Co. Company Information
7.8.2 Merck&Co. Introduction and Business Overview
7.8.3 Merck&Co. Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Merck&Co. Active Pharmaceutical Ingredient(API) Product Offerings
7.8.5 Merck&Co. Recent Development
7.9 AbbVie
7.9.1 AbbVie Company Information
7.9.2 AbbVie Introduction and Business Overview
7.9.3 AbbVie Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 AbbVie Active Pharmaceutical Ingredient(API) Product Offerings
7.9.5 AbbVie Recent Development
7.10 Biocon
7.10.1 Biocon Company Information
7.10.2 Biocon Introduction and Business Overview
7.10.3 Biocon Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Biocon Active Pharmaceutical Ingredient(API) Product Offerings
7.10.5 Biocon Recent Development
7.11 Bristol Myers Squibb
7.11.1 Bristol Myers Squibb Company Information
7.11.2 Bristol Myers Squibb Introduction and Business Overview
7.11.3 Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Product Offerings
7.11.5 Bristol Myers Squibb Recent Development
7.12 C.H.Boehringer Sohn AG&Co.KG
7.12.1 C.H.Boehringer Sohn AG&Co.KG Company Information
7.12.2 C.H.Boehringer Sohn AG&Co.KG Introduction and Business Overview
7.12.3 C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Product Offerings
7.12.5 C.H.Boehringer Sohn AG&Co.KG Recent Development
7.13 Cipla
7.13.1 Cipla Company Information
7.13.2 Cipla Introduction and Business Overview
7.13.3 Cipla Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Cipla Active Pharmaceutical Ingredient(API) Product Offerings
7.13.5 Cipla Recent Development
7.14 Albemarle Corporation
7.14.1 Albemarle Corporation Company Information
7.14.2 Albemarle Corporation Introduction and Business Overview
7.14.3 Albemarle Corporation Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Albemarle Corporation Active Pharmaceutical Ingredient(API) Product Offerings
7.14.5 Albemarle Corporation Recent Development
7.15 Viatris
7.15.1 Viatris Company Information
7.15.2 Viatris Introduction and Business Overview
7.15.3 Viatris Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Viatris Active Pharmaceutical Ingredient(API) Product Offerings
7.15.5 Viatris Recent Development
7.16 Dr. Reddy's Laboratories
7.16.1 Dr. Reddy's Laboratories Company Information
7.16.2 Dr. Reddy's Laboratories Introduction and Business Overview
7.16.3 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Product Offerings
7.16.5 Dr. Reddy's Laboratories Recent Development
8 Industry Chain Analysis
8.1 Active Pharmaceutical Ingredient(API) Industrial Chain
8.2 Active Pharmaceutical Ingredient(API) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Active Pharmaceutical Ingredient(API) Sales Model
8.5.2 Sales Channel
8.5.3 Active Pharmaceutical Ingredient(API) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Figures
Table of Figures
List of Tables
Table 1. Active Pharmaceutical Ingredient(API) Market Trends
Table 2. Active Pharmaceutical Ingredient(API) Market Drivers & Opportunity
Table 3. Active Pharmaceutical Ingredient(API) Market Challenges
Table 4. Active Pharmaceutical Ingredient(API) Market Restraints
Table 5. Global Active Pharmaceutical Ingredient(API) Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Company (2020-2025)
Table 7. Global Active Pharmaceutical Ingredient(API) Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Active Pharmaceutical Ingredient(API) Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Active Pharmaceutical Ingredient(API) Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Active Pharmaceutical Ingredient(API) Manufacturing Base and Headquarters
Table 11. Key Manufacturers Active Pharmaceutical Ingredient(API) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Active Pharmaceutical Ingredient(API)
Table 13. Global Active Pharmaceutical Ingredient(API) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredient(API) as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Active Pharmaceutical Ingredient(API) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Active Pharmaceutical Ingredient(API) Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Active Pharmaceutical Ingredient(API) Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Active Pharmaceutical Ingredient(API) Sales Market Share in Value by Type (2020-2025)
Table 20. Global Active Pharmaceutical Ingredient(API) Sales Market Share in Value by Type (2026-2031)
Table 21. Global Active Pharmaceutical Ingredient(API) Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Active Pharmaceutical Ingredient(API) Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Active Pharmaceutical Ingredient(API) Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Active Pharmaceutical Ingredient(API) Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Active Pharmaceutical Ingredient(API) Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Active Pharmaceutical Ingredient(API) Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Active Pharmaceutical Ingredient(API) Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Active Pharmaceutical Ingredient(API) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Active Pharmaceutical Ingredient(API) Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Active Pharmaceutical Ingredient(API) Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Active Pharmaceutical Ingredient(API) Sales Market Share in Value by Application (2020-2025)
Table 32. Global Active Pharmaceutical Ingredient(API) Sales Market Share in Value by Application (2026-2031)
Table 33. Global Active Pharmaceutical Ingredient(API) Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Active Pharmaceutical Ingredient(API) Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Active Pharmaceutical Ingredient(API) Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Active Pharmaceutical Ingredient(API) Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Active Pharmaceutical Ingredient(API) Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Active Pharmaceutical Ingredient(API) Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Active Pharmaceutical Ingredient(API) Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Active Pharmaceutical Ingredient(API) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Active Pharmaceutical Ingredient(API) Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Active Pharmaceutical Ingredient(API) Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Active Pharmaceutical Ingredient(API) Sales Value by Region (2020-2025) & (%)
Table 44. Global Active Pharmaceutical Ingredient(API) Sales Value by Region (2026-2031) & (%)
Table 45. Global Active Pharmaceutical Ingredient(API) Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Active Pharmaceutical Ingredient(API) Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Active Pharmaceutical Ingredient(API) Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Active Pharmaceutical Ingredient(API) Sales Volume by Region (2020-2025) & (%)
Table 49. Global Active Pharmaceutical Ingredient(API) Sales Volume by Region (2026-2031) & (%)
Table 50. Global Active Pharmaceutical Ingredient(API) Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Active Pharmaceutical Ingredient(API) Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Active Pharmaceutical Ingredient(API) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Active Pharmaceutical Ingredient(API) Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Active Pharmaceutical Ingredient(API) Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Active Pharmaceutical Ingredient(API) Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Active Pharmaceutical Ingredient(API) Sales Volume, (2026-2031) & (K Units)
Table 57. Teva Pharmaceuticals Company Information
Table 58. Teva Pharmaceuticals Introduction and Business Overview
Table 59. Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Product Offerings
Table 61. Teva Pharmaceuticals Recent Development
Table 62. Pfizer Company Information
Table 63. Pfizer Introduction and Business Overview
Table 64. Pfizer Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Pfizer Active Pharmaceutical Ingredient(API) Product Offerings
Table 66. Pfizer Recent Development
Table 67. Aurobindo Pharma Company Information
Table 68. Aurobindo Pharma Introduction and Business Overview
Table 69. Aurobindo Pharma Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Aurobindo Pharma Active Pharmaceutical Ingredient(API) Product Offerings
Table 71. Aurobindo Pharma Recent Development
Table 72. Sun Pharmaceutical Industries Ltd. Company Information
Table 73. Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 74. Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Product Offerings
Table 76. Sun Pharmaceutical Industries Ltd. Recent Development
Table 77. Novartis Company Information
Table 78. Novartis Introduction and Business Overview
Table 79. Novartis Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Novartis Active Pharmaceutical Ingredient(API) Product Offerings
Table 81. Novartis Recent Development
Table 82. Mylan Company Information
Table 83. Mylan Introduction and Business Overview
Table 84. Mylan Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Mylan Active Pharmaceutical Ingredient(API) Product Offerings
Table 86. Mylan Recent Development
Table 87. Boehringer Ingelheim Company Information
Table 88. Boehringer Ingelheim Introduction and Business Overview
Table 89. Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Product Offerings
Table 91. Boehringer Ingelheim Recent Development
Table 92. Merck&Co. Company Information
Table 93. Merck&Co. Introduction and Business Overview
Table 94. Merck&Co. Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Merck&Co. Active Pharmaceutical Ingredient(API) Product Offerings
Table 96. Merck&Co. Recent Development
Table 97. AbbVie Company Information
Table 98. AbbVie Introduction and Business Overview
Table 99. AbbVie Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. AbbVie Active Pharmaceutical Ingredient(API) Product Offerings
Table 101. AbbVie Recent Development
Table 102. Biocon Company Information
Table 103. Biocon Introduction and Business Overview
Table 104. Biocon Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Biocon Active Pharmaceutical Ingredient(API) Product Offerings
Table 106. Biocon Recent Development
Table 107. Bristol Myers Squibb Company Information
Table 108. Bristol Myers Squibb Introduction and Business Overview
Table 109. Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Product Offerings
Table 111. Bristol Myers Squibb Recent Development
Table 112. C.H.Boehringer Sohn AG&Co.KG Company Information
Table 113. C.H.Boehringer Sohn AG&Co.KG Introduction and Business Overview
Table 114. C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Product Offerings
Table 116. C.H.Boehringer Sohn AG&Co.KG Recent Development
Table 117. Cipla Company Information
Table 118. Cipla Introduction and Business Overview
Table 119. Cipla Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Cipla Active Pharmaceutical Ingredient(API) Product Offerings
Table 121. Cipla Recent Development
Table 122. Albemarle Corporation Company Information
Table 123. Albemarle Corporation Introduction and Business Overview
Table 124. Albemarle Corporation Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Albemarle Corporation Active Pharmaceutical Ingredient(API) Product Offerings
Table 126. Albemarle Corporation Recent Development
Table 127. Viatris Company Information
Table 128. Viatris Introduction and Business Overview
Table 129. Viatris Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Viatris Active Pharmaceutical Ingredient(API) Product Offerings
Table 131. Viatris Recent Development
Table 132. Dr. Reddy's Laboratories Company Information
Table 133. Dr. Reddy's Laboratories Introduction and Business Overview
Table 134. Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Product Offerings
Table 136. Dr. Reddy's Laboratories Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Active Pharmaceutical Ingredient(API) Downstream Customers
Table 140. Active Pharmaceutical Ingredient(API) Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Active Pharmaceutical Ingredient(API) Product Picture
Figure 2. Global Active Pharmaceutical Ingredient(API) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Active Pharmaceutical Ingredient(API) Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Active Pharmaceutical Ingredient(API) Sales Volume (2020-2031) & (K Units)
Figure 5. Global Active Pharmaceutical Ingredient(API) Sales Price (2020-2031) & (US$/Unit)
Figure 6. Active Pharmaceutical Ingredient(API) Report Years Considered
Figure 7. Global Active Pharmaceutical Ingredient(API) Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Active Pharmaceutical Ingredient(API) Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Active Pharmaceutical Ingredient(API) Revenue in 2024
Figure 10. Active Pharmaceutical Ingredient(API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Generic API Picture
Figure 12. Innovative API Picture
Figure 13. Global Active Pharmaceutical Ingredient(API) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Active Pharmaceutical Ingredient(API) Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Active Pharmaceutical Ingredient(API) Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 16. Global Active Pharmaceutical Ingredient(API) Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Active Pharmaceutical Ingredient(API) Price by Type (2020-2031) & (US$/Unit)
Figure 18. Product Picture of Oncology
Figure 19. Product Picture of Cardiology
Figure 20. Product Picture of Cns and Neurology
Figure 21. Product Picture of Orthopaedic
Figure 22. Product Picture of Pulmonology
Figure 23. Product Picture of Gastroenterology
Figure 24. Product Picture of Nephrology
Figure 25. Product Picture of Ophthalmology
Figure 26. Product Picture of Endocrinology
Figure 27. Global Active Pharmaceutical Ingredient(API) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 28. Global Active Pharmaceutical Ingredient(API) Sales Value Market Share by Application, 2024 & 2031
Figure 29. Global Active Pharmaceutical Ingredient(API) Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 30. Global Active Pharmaceutical Ingredient(API) Sales Volume Market Share by Application, 2024 & 2031
Figure 31. Global Active Pharmaceutical Ingredient(API) Price by Application (2020-2031) & (US$/Unit)
Figure 32. North America Active Pharmaceutical Ingredient(API) Sales Value (2020-2031) & (US$ Million)
Figure 33. North America Active Pharmaceutical Ingredient(API) Sales Value by Country (%), 2024 VS 2031
Figure 34. Europe Active Pharmaceutical Ingredient(API) Sales Value, (2020-2031) & (US$ Million)
Figure 35. Europe Active Pharmaceutical Ingredient(API) Sales Value by Country (%), 2024 VS 2031
Figure 36. Asia Pacific Active Pharmaceutical Ingredient(API) Sales Value, (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Active Pharmaceutical Ingredient(API) Sales Value by Region (%), 2024 VS 2031
Figure 38. South America Active Pharmaceutical Ingredient(API) Sales Value, (2020-2031) & (US$ Million)
Figure 39. South America Active Pharmaceutical Ingredient(API) Sales Value by Country (%), 2024 VS 2031
Figure 40. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Value, (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Value by Country (%), 2024 VS 2031
Figure 42. Key Countries/Regions Active Pharmaceutical Ingredient(API) Sales Value (%), (2020-2031)
Figure 43. Key Countries/Regions Active Pharmaceutical Ingredient(API) Sales Volume (%), (2020-2031)
Figure 44. United States Active Pharmaceutical Ingredient(API) Sales Value, (2020-2031) & (US$ Million)
Figure 45. United States Active Pharmaceutical Ingredient(API) Sales Value by Type (%), 2024 VS 2031
Figure 46. United States Active Pharmaceutical Ingredient(API) Sales Value by Application (%), 2024 VS 2031
Figure 47. Europe Active Pharmaceutical Ingredient(API) Sales Value, (2020-2031) & (US$ Million)
Figure 48. Europe Active Pharmaceutical Ingredient(API) Sales Value by Type (%), 2024 VS 2031
Figure 49. Europe Active Pharmaceutical Ingredient(API) Sales Value by Application (%), 2024 VS 2031
Figure 50. China Active Pharmaceutical Ingredient(API) Sales Value, (2020-2031) & (US$ Million)
Figure 51. China Active Pharmaceutical Ingredient(API) Sales Value by Type (%), 2024 VS 2031
Figure 52. China Active Pharmaceutical Ingredient(API) Sales Value by Application (%), 2024 VS 2031
Figure 53. Japan Active Pharmaceutical Ingredient(API) Sales Value, (2020-2031) & (US$ Million)
Figure 54. Japan Active Pharmaceutical Ingredient(API) Sales Value by Type (%), 2024 VS 2031
Figure 55. Japan Active Pharmaceutical Ingredient(API) Sales Value by Application (%), 2024 VS 2031
Figure 56. South Korea Active Pharmaceutical Ingredient(API) Sales Value, (2020-2031) & (US$ Million)
Figure 57. South Korea Active Pharmaceutical Ingredient(API) Sales Value by Type (%), 2024 VS 2031
Figure 58. South Korea Active Pharmaceutical Ingredient(API) Sales Value by Application (%), 2024 VS 2031
Figure 59. Southeast Asia Active Pharmaceutical Ingredient(API) Sales Value, (2020-2031) & (US$ Million)
Figure 60. Southeast Asia Active Pharmaceutical Ingredient(API) Sales Value by Type (%), 2024 VS 2031
Figure 61. Southeast Asia Active Pharmaceutical Ingredient(API) Sales Value by Application (%), 2024 VS 2031
Figure 62. India Active Pharmaceutical Ingredient(API) Sales Value, (2020-2031) & (US$ Million)
Figure 63. India Active Pharmaceutical Ingredient(API) Sales Value by Type (%), 2024 VS 2031
Figure 64. India Active Pharmaceutical Ingredient(API) Sales Value by Application (%), 2024 VS 2031
Figure 65. Active Pharmaceutical Ingredient(API) Industrial Chain
Figure 66. Active Pharmaceutical Ingredient(API) Manufacturing Cost Structure
Figure 67. Channels of Distribution (Direct Sales, and Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
